Abstract
In translational medicine, the discovery of new drugs or new potential uses for currently available drugs is crucial for treating the resistant hypertension associated with renal artery stenosis. The phosphodiesterase 5 inhibitor sildenafil has been shown to reduce blood pressure and to improve the endothelium-dependent relaxation in the two kidney, one clip (2K1C) mouse model of renovascular hypertension. In the present study, we evaluated the effects of sildenafil (40 mg/kg/day for two weeks) on the endothelial structure and contractile function in mesenteric resistance arteries 28 days after clipping the renal artery. The data showed an enhanced vascular contractile response to norepinephrine in 2K1C hypertensive mice (56%) when compared with Sham mice, which was associated with increased oxidative stress and with a thinning of endothelial cells. Sildenafil treatment caused a significant amelioration in the enhanced contractile responsiveness (18%), which was associated to the recovery of the endothelial surface and abolishment of the oxidative stress. These data suggest that sildenafil could be considered a promising therapeutic option to manage endothelial dysfunction and hypertension in resistant patients.
Keywords: 2K1C, endothelial cells, endothelial dysfunction, renovascular hypertension, resistance arteries, sildenafil.
Current Pharmaceutical Biotechnology
Title:Sildenafil Improves Vascular Endothelial Structure and Function in Renovascular Hypertension
Volume: 16 Issue: 9
Author(s): Bernah M. Fahning, Ananda T. Dias, Jairo P. Oliveira, Agata L. Gava, Marcella L. Porto, Isabele B.S. Gomes, Breno V. Nogueira, Bianca P. Campagnaro, Thiago M.C. Pereira, Elisardo C. Vasquez, Camille M. Balarini and Silvana S. Meyrelles
Affiliation:
Keywords: 2K1C, endothelial cells, endothelial dysfunction, renovascular hypertension, resistance arteries, sildenafil.
Abstract: In translational medicine, the discovery of new drugs or new potential uses for currently available drugs is crucial for treating the resistant hypertension associated with renal artery stenosis. The phosphodiesterase 5 inhibitor sildenafil has been shown to reduce blood pressure and to improve the endothelium-dependent relaxation in the two kidney, one clip (2K1C) mouse model of renovascular hypertension. In the present study, we evaluated the effects of sildenafil (40 mg/kg/day for two weeks) on the endothelial structure and contractile function in mesenteric resistance arteries 28 days after clipping the renal artery. The data showed an enhanced vascular contractile response to norepinephrine in 2K1C hypertensive mice (56%) when compared with Sham mice, which was associated with increased oxidative stress and with a thinning of endothelial cells. Sildenafil treatment caused a significant amelioration in the enhanced contractile responsiveness (18%), which was associated to the recovery of the endothelial surface and abolishment of the oxidative stress. These data suggest that sildenafil could be considered a promising therapeutic option to manage endothelial dysfunction and hypertension in resistant patients.
Export Options
About this article
Cite this article as:
Fahning M. Bernah, Dias T. Ananda, Oliveira P. Jairo, Gava L. Agata, Porto L. Marcella, Gomes B.S. Isabele, Nogueira V. Breno, Campagnaro P. Bianca, Pereira M.C. Thiago, Vasquez C. Elisardo, Balarini M. Camille and Meyrelles S. Silvana, Sildenafil Improves Vascular Endothelial Structure and Function in Renovascular Hypertension, Current Pharmaceutical Biotechnology 2015; 16 (9) . https://dx.doi.org/10.2174/1389201016666150610161330
DOI https://dx.doi.org/10.2174/1389201016666150610161330 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanisms of Endogenous Endothelial Repair in Stroke
Current Pharmaceutical Design The Status of Biochemical and Molecular Markers of Oxidative Stress in Preeclamptic Saudi Patients
Current Molecular Medicine Neonatal Hypertension: An Underdiagnosed Condition, A Review Article
Current Hypertension Reviews Association of Serum Uric Acid and Metabolic Syndrome in Type 2 Diabetes
Current Diabetes Reviews The Association of Metabolic Syndrome and Psoriasis: A Systematic Review and Meta-Analysis of Observational Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Mind-Body Therapies and Osteoarthritis of the Knee
Current Rheumatology Reviews Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery Binding Interactions of Forskolin with Human Serum Albumin: Insights from In silico and Spectroscopic Studies
Current Chemical Biology Antithrombotic Treatment after Atrial Fibrillation Ablation
Current Pharmaceutical Design Therapies Targeting Inflammation After Stent Implantation
Current Vascular Pharmacology Personalization of Targeted Therapy in Advanced Thyroid Cancer
Current Genomics Centrality Measures in Biological Networks
Current Bioinformatics Pulmonary Complications After Congenital Heart Surgery
Current Respiratory Medicine Reviews Neuronal Histamine and its Receptors: Implication of the Pharmacological Treatment of Obesity
Current Medicinal Chemistry Biomarkers of Angiogenesis and their Role in Patient Selection for Antiangiogenic Therapy
Current Angiogenesis (Discontinued) Exercise-Induced Modulation of Endothelial Nitric Oxide Production
Current Pharmaceutical Biotechnology Withdrawal Notice: Mucoadhesive Microspheres: An Emerging Trends in Therapy of Diabetes Mellitus
Current Diabetes Reviews Endocannabinoids and their Involvement in the Neurovascular System
Current Neurovascular Research Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension
Current Vascular Pharmacology Mixed Connective Tissue Disease, a Roundabout to Rheumatic Diseases?
Current Rheumatology Reviews